BREAST ATYPICAL HYPERPLASIA
Clinical trials for BREAST ATYPICAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new BREAST ATYPICAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for BREAST ATYPICAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can fish oil boost Tamoxifen's Cancer-Fighting power?
Prevention Recruiting nowThis study looks at whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can better reduce breast cancer risk in overweight postmenopausal women who are already at higher risk. Tamoxifen blocks estrogen, which can fuel some breast cancers, while omega-3s may help wi…
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 17, 2026 00:49 UTC
-
New hope for High-Risk women: can acolbifene outdo tamoxifen in breast cancer prevention?
Prevention Recruiting nowThis study tests two drugs, acolbifene and low-dose tamoxifen, to see which works better at preventing breast cancer in premenopausal women at high risk. Both drugs block estrogen from fueling breast cell growth. About 80 women will take one of the drugs for six months, and resea…
Matched conditions: BREAST ATYPICAL HYPERPLASIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 14, 2026 12:05 UTC